About Coley Pharmaceutical
Coley Pharmaceutical is a company based in Wellesley (United States) founded in 1997 was acquired by Pfizer in November 2007.. Coley Pharmaceutical has raised $55 million across 2 funding rounds from investors including Pfizer, Thomas, McNerney & Partners and Venrock. Coley Pharmaceutical operates in a competitive market with competitors including Emergent BioSolutions, Adjuvance Technologies, EyeGene, Kineta and Eikonoklastes, among others.
- Headquarter Wellesley, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Coley Pharmaceutical
Coley Pharmaceutical has successfully raised a total of $55M across 2 strategic funding rounds. The most recent funding activity was a Series F round of $25 million completed in September 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series F — $25.0M
-
First Round
First Round
(25 Aug 2003)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2004 | Amount | Series F - Coley Pharmaceutical | Valuation |
investors |
|
| Aug, 2003 | Amount | Series E - Coley Pharmaceutical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Coley Pharmaceutical
Coley Pharmaceutical has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Thomas, McNerney & Partners and Venrock. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location | |
|
Early & late stage life sciences focused VC firm funding companies in the US and Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Coley Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Coley Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Coley Pharmaceutical Comparisons
Competitors of Coley Pharmaceutical
Coley Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emergent BioSolutions, Adjuvance Technologies, EyeGene, Kineta and Eikonoklastes, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccines for viral infections are developed by the company.
|
|
| domain | founded_year | HQ Location |
Vaccine adjuvants are designed and manufactured for medical applications.
|
|
| domain | founded_year | HQ Location |
Immune vaccines and diagnostics for ocular diseases are developed.
|
|
| domain | founded_year | HQ Location |
Immune-modulating therapeutics are developed for autoimmune and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Tissue factor targeting therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Coley Pharmaceutical
When was Coley Pharmaceutical founded?
Coley Pharmaceutical was founded in 1997 and raised its 1st funding round 6 years after it was founded.
Where is Coley Pharmaceutical located?
Coley Pharmaceutical is headquartered in Wellesley, United States. It is registered at Wellesley, Massachusetts, United States.
Is Coley Pharmaceutical a funded company?
Coley Pharmaceutical is a funded company, having raised a total of $55M across 2 funding rounds to date. The company's 1st funding round was a Series E of $30M, raised on Aug 25, 2003.
What does Coley Pharmaceutical do?
Coley Pharmaceutical was founded in 1997 in Wellesley, United States, within the biotechnology sector. Focus was placed on developing immunomodulatory drugs that targeted Toll-like Receptors (TLR) 7, 8, and 9 as immune modulators. These candidates were tested across areas including cancer, asthma, Alzheimers disease, and infectious diseases. Vaccine adjuvants were also developed and commercialized. Acquisition by Pfizer occurred in November 2007 for 164 million.
Who are the top competitors of Coley Pharmaceutical?
Coley Pharmaceutical's top competitors include Adjuvance Technologies, Emergent BioSolutions and Kineta.
Who are Coley Pharmaceutical's investors?
Coley Pharmaceutical has 5 investors. Key investors include Pfizer, Thomas, McNerney & Partners, Venrock, Global Life Science Ventures, and TVM Capital Life Science.